Cardiac toxicity of arsenic trioxide

Unnikrishnan et al have reported the occurrence of torsades de pointes in 3 of 19 patients treated with arsenic trioxide.[1][1] The propensity for arsenic to cause reversible Q-T interval prolongation is well known and has previously been characterized.[2][2] To minimize the risk of long Q-T–